- Home
- ADAP vs INGN Comparison
ADAP vs INGN Comparison
Compare ADAP & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- INGN
- Stock Information
- Founded
- ADAP 2008
- INGN 2001
- Country
- ADAP United Kingdom
- INGN United States
- Employees
- ADAP N/A
- INGN N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- INGN Industrial Specialties
- Sector
- ADAP Health Care
- INGN Health Care
- Exchange
- ADAP Nasdaq
- INGN Nasdaq
- Market Cap
- ADAP 212.3M
- INGN 222.0M
- IPO Year
- ADAP 2015
- INGN 2014
- Fundamental
- Price
- ADAP $0.59
- INGN $10.05
- Analyst Decision
- ADAP Strong Buy
- INGN Hold
- Analyst Count
- ADAP 4
- INGN 3
- Target Price
- ADAP $3.16
- INGN $7.00
- AVG Volume (30 Days)
- ADAP 2.0M
- INGN 220.9K
- Earning Date
- ADAP 11-13-2024
- INGN 11-07-2024
- Dividend Yield
- ADAP N/A
- INGN N/A
- EPS Growth
- ADAP N/A
- INGN N/A
- EPS
- ADAP N/A
- INGN N/A
- Revenue
- ADAP $175,041,000.00
- INGN $331,520,000.00
- Revenue This Year
- ADAP $180.15
- INGN $6.09
- Revenue Next Year
- ADAP N/A
- INGN $4.17
- P/E Ratio
- ADAP N/A
- INGN N/A
- Revenue Growth
- ADAP 146.27
- INGN 1.12
- 52 Week Low
- ADAP $0.42
- INGN $4.93
- 52 Week High
- ADAP $2.05
- INGN $13.33
- Technical
- Relative Strength Index (RSI)
- ADAP 26.22
- INGN 54.02
- Support Level
- ADAP $0.75
- INGN $10.25
- Resistance Level
- ADAP $0.83
- INGN $11.65
- Average True Range (ATR)
- ADAP 0.07
- INGN 0.51
- MACD
- ADAP -0.01
- INGN 0.12
- Stochastic Oscillator
- ADAP 2.36
- INGN 48.88
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.
About INGN Inogen Inc
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.